Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-18 12:29 pm Sale |
2024-09-30 | 13G | Vir Biotechnology, Inc. VIR |
STATE STREET CORP STT |
5,625,533 4.100% |
-1,286,549 (-18.61%) |
Filing History |
| 2024-02-13 5:17 pm Purchase |
2023-12-29 | 13G | Vir Biotechnology, Inc. VIR |
The Vanguard Group | 12,297,139 9.140% |
2,202,638 (+21.82%) |
Filing History |
| 2024-02-13 5:00 pm Purchase |
2023-12-31 | 13G | Vir Biotechnology, Inc. VIR |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 12.400% |
16,684,041 (New Position) |
Filing History |
| 2024-01-24 07:59 am Purchase |
2023-12-31 | 13G | Vir Biotechnology, Inc. VIR |
STATE STREET CORP STT |
6,912,082 5.140% |
6,912,082 (New Position) |
Filing History |
| 2024-01-23 4:14 pm Purchase |
2023-12-31 | 13G | Vir Biotechnology, Inc. VIR |
BLACKROCK INC BLK |
16,864,579 12.500% |
2,727,951 (+19.30%) |
Filing History |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | Vir Biotechnology, Inc. VIR |
SOFTBANK VISION FUND (AIV M1) L.P. | 20,259,535 15.200% |
-2,357,131 (-10.42%) |
Filing History |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Vir Biotechnology, Inc. VIR |
The Vanguard Group | 10,094,501 7.580% |
2,764,370 (+37.71%) |
Filing History |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Vir Biotechnology, Inc. VIR |
BLACKROCK INC BLK |
14,136,628 10.600% |
752,434 (+5.62%) |
Filing History |
| 2022-09-13 3:45 pm Sale |
2022-08-12 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 13,552,310 10.200% |
-5,636,784 (-29.37%) |
Filing History |
| 2022-09-08 1:43 pm Purchase |
2022-08-31 | 13G | Vir Biotechnology, Inc. VIR |
BLACKROCK INC BLK |
13,384,194 10.100% |
13,384,194 (New Position) |
Filing History |
| 2022-05-10 5:05 pm Purchase |
2021-12-20 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 19,189,094 14.700% |
3,374 (+0.02%) |
Filing History |
| 2022-02-14 4:05 pm Sale |
2021-12-31 | 13G | Vir Biotechnology, Inc. VIR |
SCANGOS GEORGE A | 6,266,581 4.790% |
-734,727 (-10.49%) |
Filing History |
| 2022-02-11 11:19 am Sale |
2022-02-14 | 13G | Vir Biotechnology, Inc. VIR |
Capital International Investors | 5,634,019 4.300% |
-5,806,552 (-50.75%) |
Filing History |
| 2022-02-10 4:46 pm Purchase |
2021-12-31 | 13G | Vir Biotechnology, Inc. VIR |
GLAXOSMITHKLINE PLC | 8,550,954 6.500% |
1,924,927 (+29.05%) |
Filing History |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Vir Biotechnology, Inc. VIR |
The Vanguard Group | 7,330,131 5.600% |
7,330,131 (New Position) |
Filing History |
| 2022-01-10 5:02 pm Sale |
2021-12-20 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 19,185,720 14.700% |
-2,589,653 (-11.89%) |
Filing History |
| 2021-07-12 5:02 pm Sale |
2021-06-22 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 21,775,373 16.700% |
-4,915,244 (-18.42%) |
Filing History |
| 2021-04-14 5:23 pm Sale |
2021-03-30 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 26,690,617 20.900% |
-1,976,046 (-6.89%) |
Filing History |
| 2021-02-16 2:24 pm Unchanged |
2021-02-16 | 13G | Vir Biotechnology, Inc. VIR |
Capital International Investors | 11,440,571 9.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 1:57 pm Purchase |
2021-02-16 | 13G | Vir Biotechnology, Inc. VIR |
Capital International Investors | 11,440,571 9.000% |
11,440,571 (New Position) |
Filing History |